Invention Grant
- Patent Title: AKT nucleic acids, polypeptides, and uses thereof
- Patent Title (中): AKT核酸，多肽及其用途
-
Application No.: US12633984Application Date: 2009-12-09
-
Publication No.: US07989584B2Publication Date: 2011-08-02
- Inventor: Kun Guo , Kenneth L. Clark , Yuri D. Ivashchenko , Marco Pagnoni
- Applicant: Kun Guo , Kenneth L. Clark , Yuri D. Ivashchenko , Marco Pagnoni
- Applicant Address: US NJ Bridgewater
- Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee Address: US NJ Bridgewater
- Main IPC: C07K14/17
- IPC: C07K14/17 ; C07K19/00 ; C12N15/12
Abstract:
The present invention relates to human Akt3 proteins and polypeptides. The invention also relates to isolated nucleic acids encoding human Akt3, to vectors containing them and to their therapeutic uses, in particular for gene therapy. Expression of Akt3 inhibits cell death associated with hypoxia, apoptosis or necrosis.
Public/Granted literature
- US20100143308A1 AKT NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF Public/Granted day:2010-06-10
Information query
